This additional funding comes at the heels of Selux announcing their third FDA 510(k) clearance on their direct from Positive Blood Culture Separator, making them the only single-platform technology capable of delivering rapid AST results for both positive blood culture and isolated colonies.
Read Press ReleaseGeneral Catalyst leads funding round joined by .406 Ventures, Valtruis, Mass General Brigham Ventures, and Hopelab Foundation to bolster insurance-based mental health program availability in new markets
Read Press ReleaseAdMeTech Foundation’s 15th Annual Prostate Cancer Awareness Day Highlights Massachusetts Model of National Leadership in Public Awareness, Medical Education, Research, Clinical Care and Equity
Read Press ReleasePeterson Capital Group LLC presents a buoyant forecast for global equities, anchored by technological advancements and a strategic economic analysis. This optimism underscores the potential for strategic investments to thrive in a dynamically evolving financial landscape.
Read Press Release